Inventor · disambiguated record
Chitase Lee
Also filed as: LEE CHITASE
22 granted patents·8 pending applications·149 citations·filing 1994–2024
95Inventor score
Top patents by PatentIndex Score
30 records- 0195US8513436B2Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsANDERSON ERIC·Filed 2011·Granted Aug 20, 2013·29 cites·112 claims
- 0294US9174941B2Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsREATA PHARMACEUTICALS INC·Filed 2013·Granted Nov 3, 2015·22 cites·7 claims
- 0393US9884809B2Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsREATA PHARMACEUTICALS INC·Filed 2015·Granted Feb 6, 2018·11 cites·11 claims
- 0492US9464082B2Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsABBVIE INC·Filed 2015·Granted Oct 11, 2016·18 cites·24 claims
- 0588US11192852B2Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsREATA PHARMACEUTICALS INC·Filed 2019·Granted Dec 7, 2021·2 cites·21 claims
- 0687US11292781B2Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other usesREATA PHARMACEUTICALS INC·Filed 2017·Granted Apr 5, 2022·4 cites·40 claims
- 0784US11827664B2Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathwayREATA PHARMACEUTICALS INC·Filed 2019·Granted Nov 28, 2023·1 cites·17 claims
- 0882US11814338B2Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsREATA PHARMACEUTICALS INC·Filed 2021·Granted Nov 14, 2023·0 cites·37 claims
- 0982US7244763B2Compounds that modulate PPAR activity and methods of preparationWARNER LAMBERT CO·Filed 2004·Granted Jul 17, 2007·20 cites·46 claims
- 1079US2025188053A1Pyrimidine tricyclic enone derivatives for inhibition of ror-gamma and other usesREATA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1177US7109222B2Compounds that modulate PPAR activity and methods of preparationWARNER LAMBERT CO·Filed 2004·Granted Sep 19, 2006·8 cites·8 claims
- 1276US5658902AQuinazolines as inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1994·Granted Aug 19, 1997·16 cites·13 claims
- 1374US6867224B2Compounds that modulate PPAR activity and methods of preparationWARNER LAMBERT CO·Filed 2002·Granted Mar 15, 2005·6 cites·11 claims
- 1471US2024360084A1Pyrazole and imidazole compounds for inhibition of il-17 and rorgammaREATA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1570US12195443B2Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other usesREATA PHARMACEUTICALS INC·Filed 2022·Granted Jan 14, 2025·0 cites·35 claims
- 1669US11059792B2Imidazolyl tricyclic enones as antioxidant inflammation modulatorsREATA PHARMACEUTICALS INC·Filed 2016·Granted Jul 13, 2021·1 cites·9 claims
- 1767US6252070B1Certain benzothiazine dioxide endothelin antagonists and processes for their preparationWARNER LAMBERT CO·Filed 2000·Granted Jun 26, 2001·2 cites·2 claims
- 1863US6545150B2Certain benzothiazine dioxide endothelin antagonists and processes for their preparationWARNER LAMBERT CO·Filed 2001·Granted Apr 8, 2003·1 cites·2 claims
- 1963US2018265455A1Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsREATA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2061US11584775B2C4-modified oleanolic acid derivatives for inhibition of IL-17 and other usesREATA PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2023·0 cites·10 claims
- 2160US6833380B2Compounds that modulate PPAR activity and methods of preparationWARNER LAMBERT CO·Filed 2002·Granted Dec 21, 2004·1 cites·30 claims
- 2256US2005113422A1Compounds that modulate PPAR activity and methods of preparationFiled 2004·Application pending·0 cites
- 2354US11993574B2Pyrazole and imidazole compounds for inhibition of IL-17 and RORgammaREATA PHARMACEUTICALS INC·Filed 2019·Granted May 28, 2024·0 cites·37 claims
- 2454US5773444AQuinazolines as inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1997·Granted Jun 30, 1998·5 cites·5 claims
- 2552US2003073684A1Certain benzothiazine dioxide endothelin antagonists and processes for their preparationFiled 2002·Application pending·0 cites
- 2650US6440962B2Certain benzothiazine dioxide endothelin antagonists and processes for their preparationWARNER LAMBERT CO·Filed 2001·Granted Aug 27, 2002·0 cites·5 claims
- 2746US2005154042A1N-alkyl pyrroles as HMG-CoA reductase inhibitorsFiled 2004·Application pending·0 cites
- 2843US2010029710A1COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIESPFIZER PROD INC·Filed 2007·Application pending·0 cites
- 2940US2003207924A1Compounds that modulate PPAR activity and methods of preparationFiled 2002·Application pending·0 cites
- 3039US6265399B1Certain benzothiazine dioxide endothelin antagonists and processes for their preparationWARNER LAMBERT CO·Filed 1998·Granted Jul 24, 2001·2 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Chitase Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →